CD147, a highly glycosylated member of the immunoglobulin superfamily expressed on the surface of many malignant tumors, such as ovarian cancer and bladder cancer [18-20], is also positively expressed in up to 88.7% of patients with advanced RCC [21]. The gene discussed is BSG; the disease is cancer.